Dr. Clifton E. Barry III received his Ph.D. degree in Organic and Bioorganic Chemistry in 1989 from Cornell University, studying the biosynthesis of complex natural products. Following the postdoctoral research in the Chemistry Department at Johns Hopkins University (1989 to 1992), he joined the NIH Intramural Research Program at the NIAID Rocky Mountain Laboratories in Hamilton, Montana. In 1998, he was tenured as chief of the Tuberculosis Research Section (TBRS) in the Laboratory of Clinical Infectious Diseases. He is a member of several editorial boards and has authored more than 120 research publications on tuberculosis. He is also an Honorary Professor at the Institute for Infectious Diseases and Molecular Medicine at the University of Cape Town where he operates laboratory and clinical research facilities.
Dr. Clifton E. Barry III received his Ph.D. degree in Organic and Bioorganic Chemistry in 1989 from Cornell University, studying the biosynthesis of complex natural products. Following the postdoctoral research in the Chemistry Department at Johns Hopkins University (1989 to 1992), he joined the NIH Intramural Research Program at the NIAID Rocky Mountain Laboratories in Hamilton, Montana. In 1998, he was tenured as chief of the Tuberculosis Research Section (TBRS) in the Laboratory of Clinical Infectious Diseases. He is a member of several editorial boards and has authored more than 120 research publications on tuberculosis. He is also an Honorary Professor at the Institute for Infectious Diseases and Molecular Medicine at the University of Cape Town where he operates laboratory and clinical research facilities.